Hadassah

Hadassah Cardiologists Find That Vitamin D Supplementation Increases Survival for Heart Failure Patients

Sunday, Aug 5 2012

Noting that Vitamin D deficiency is "highly prevalent" in patients with heart failure (HF) and "a significant predictor of reduced survival," Hadassah Medical Center physicians determined that Vitamin D supplementation was associated with improved outcome.

The researchers reported their findings in the April 2012 issue of The European Journal of Heart Failure, the international journal of the European Society of Cardiology, dedicated to the advancement of knowledge in the field of heart failure.

Vitamin D deficiency was found in 28 percent of the HF patients, as compared to 22 percent in the control group. Only 8.8% of the HF patients, they found, had optimal levels of Vitamin D. Those HF patients who received Vitamin D supplementation, however, were 32 percent less likely to die from the disease.


Read more on Foodconsumer.org here>>

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More